Partnering
We’re the partner of choice for the world’s most innovative biopharma companies. ElevateBio provides its enabling technologies, manufacturing capabilities, and industry-leading expertise through partnerships to accelerate development across a breadth of therapeutic approaches and modalities.
// Partnering
Why ElevateBio?
We have integrated a differentiated set of platform technologies, including full-spectrum gene editing, with industry-leading manufacturing expertise to develop genetic medicines faster and more efficiently.
ElevateBio’s technology forward approach gives our partners access to the latest innovations and capabilities to accelerate medicines to patients.
Let us be Your Guide Through Every Stage of Development, From Drug Discovery to the Clinic to Commercial Manufacturing
ElevateBio is more than a service provider, we are a strategic partner on your expedition, offering the necessary resources, unparalleled expertise, unmatched quality, and high-touch costumer service needed to make your journey faster and smoother.
End-to End capabilities to Accelerate Cell and Gene Therapies from Bench to Bedside
- Streamline path to the clinic with integrated components, capabilities, and resources
- De-risk development path by having the necessary technology systems and expertise at every step
- Accelerate development timelines by having end-to-end capabilities under one roof
Our Partnership Spotlights
Broadening the Potential of CRISPR Gene Editing Therapies with Generative AI
ElevateBio formed a multi-year collaboration with Amazon Web Services (AWS) to accelerate the discovery and development of CRISPR gene editing therapeutics through generative artificial intelligence. ElevateBio Life Edit is combining its large CRISPR data set with AWS’s cloud infrastructure to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex monogenic and polygenic diseases.
Discover and Develop Gene Editing Therapies for Rare and Cardiometabolic Diseases with Novo Nordisk
Life Edit formed a strategic collaboration with Novo Nordisk to discover, develop, and deliver base editing therapies for rare and cardiometabolic diseases. Novo Nordisk will leverage Life Edit’s suite of gene editing technologies to precisely edit the genome with the aim of developing life-changing therapies.
Extending Our Manufacturing Footprint to Accelerate Cell and Gene Therapies or Expanding Clinical Through Commercial Manufacturing Capacity
ElevateBio partnered with the University of Pittsburgh to develop a new ~125,000 sf BaseCamp biomanufacturing facility in Pittsburgh anticipated to be completed in 2027. The facility will be fully equipped with cell and gene therapy-enabling technologies, including gene editing, induced pluripotent stem cell (iPSC) and cell, vector, and protein engineering capabilities.
Leveraging our Process Development and Clinical Manufacturing
ElevateBio BaseCamp partnered with Kyverna Therapeutics to advance process development and manufacturing to produce industry-leading Ingenui-T-derived chimeric antigen receptor (CAR) T-cell therapies. Ingenui-T is an optimized autologous manufacturing platform developed by Kyverna to specifically address the needs of patients with autoimmune diseases
Partner Testimonials
The speed and quality of this collaboration exceeded our expectations. BaseCamp didn't just manufacture our therapy – they helped us establish a blueprint for base editing manufacturing
We have some exceptional emerging research coming out of the University of Pittsburgh. However, the missing ingredient has been access to high-quality process science and manufacturing capabilities. As we position ourselves to become the next global hub for life sciences and biotech, we were in search of the right partner to help us realize our vision, and ElevateBio’s expertise and reputation in cell and gene therapy made them the perfect partner to accelerate our ability to build our biomanufacturing center of excellence.
cGMP Manufacturing, Process Development and Analytical Development Services
ElevateBio BaseCamp is our cGMP manufacturing business, designed to deliver genetic medicines from concept through commercialization.
Gene Editing Technologies and R&D
ElevateBio Life Edit is our gene editing technologies and R&D business, featuring one of the world’s largest and most diverse libraries of RNA-guided editing libraries, opening a new frontier of medicine.
Team of Industry-Leading Experts
We have assembled a leading team of experts with first-hand experience in the discovery, development, and manufacturing of cell and gene therapies. Driven by a common mission to power life-changing therapies, the team works to advance discoveries and development at a speed the world demands.
Partner With Us
Wherever you are in your cell and gene therapy product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies and unmatched manufacturing capabilities.
// Work with us
